Indonesian Tobacco Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indonesian Tobacco Tbk. trades at Rp224 (market cap 210.72B, 104.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indonesian Tobacco Tbk. is far larger — about 2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ITIC | SCPI | |
|---|---|---|
Market Cap | 210.72B | 104.4B |
Volume | 104.7K | — |
Lot | 1.05K | — |
Turnover | 23.59M | — |
Average Price | 225.34 | — |
Value | 23.59M | — |
Indicative Equilibrium Price | 224 | — |
Indicative Equilibrium Volume | 201 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesian Tobacco Tbk (the Company) was established in Notarial Deed No. 25 dated May 16, 1955 of Public Notary H. Chusen Bisri, S.H. under the name of N.V. Indonesian Tobacco & Industrial Company approved by the Minister of Justice of the deed of Establishment Republic of Indonesia in Decision Letter No. J.A.5/61/3 dated June 16, 1955 and was published in State Gazette of the Republic of Indonesia No. 478 dated June 22, 1956, Supplement No. 50.
Read more on ITIC →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →